The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 52-55

  Rooprai, H K ^a   Rucklidge, G J ^b   Panou, C ^a   Pilkington, G J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Brain tumour invasion; Growth factors; Matrix metalloproteinases

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER INVASION; CELL LINE; EMBRYO DEVELOPMENT; ENZYME RELEASE; ENZYME SYNTHESIS; EPENDYMOMA; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; HUMAN CELL; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; ZYMOGRAPHY;

EID: 0033989425     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0876     Document Type: Article

References (33)

1. Engebraaten O, Bjerkvig R, Pedersen PH and Laerum OD (1993) Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain tumour biopsies in vitro. Int J Cancer 53: 209-214
2. Finn PE, Bjerkvig R and Pilkington GJ (1997) The role of growth factors in the malignant and invasive progression of intrinsic brain tumours. Anticancer Res 17: 4163-4172
3. Heldin C-H and Westermark B (1989) Growth factors as transforming proteins. Eur J Biochem 184: 487-496
4. Heussen C and Dowdle EB (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodocyl sulfate and copolymerized substrates. Anal Biochem 102: 196-202
5. Kleihues P, Burger C and Scheithauer BW (1993) Histological typing of tumours of the central nervous system. In: WHO Classification, 2nd edn. Springer Verlag: Berlin
6. Koochekpour S, Merzak A and Pilkington GJ (1995) Growth factors and gangliosides stimulate laminin production by human glioma cells in vitro. Neurosci Lett 186: 53-56
7. Laerum OD (1998) The role of growth factors and oncogenes in tumour cell invasion. In: Brain Tumour Invasion: Biological, Clinical and Therapeutic Considerations, Mikkelsen, Bjerkvig R, Laerum OD and Rosenblum (eds), pp. 323-341
8. Lamoreaux WJ, Fitzgerald MEC, Reiner A, Hasty KA and Charles ST (1998) Vascular endothelial growth factor increases release of gelatinase A and decrease release of tissue inhibitors of metalloproteinases by microvascular endothelial cells in vitro. Microvascular Res 55: 29-42
9. Liotta LA (1986) Tumor invasion and metastases: role of the extracellular matrix (Rhodes Memorial Award Lecture). Cancer Res 46: 1-7
10. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD and Laerum OD (1990) Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro. Cancer Res 50: 6039-6044
11. Lund-Johansen M, Forsberg K, Bjerkvig R and Laerum OD (1992) Effects of growth factors on human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropath 84: 190-197
12. McDougall JR and Matrisian LM (1995) Contribution of tumour and stromal matrix melalloproteinases to tumour progression, invasion and metastasis. Cancer and Metastas Rev 14: 351-362
13. Maidment SL, Merzak A, Koochekpour S, Rooprai HK, Rucklidge GJ and Pilkington GJ (1996) The effects of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro. Eur J Cancer r 32: 868-871
14. Merzak A, McCrea S, Koochekpour S and Pilkington GJ (1994) Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta-1. Br J Cancer 70: 199-203
15. Merzak A, Koochekpour S, Dkhissi F, Raynal S, Lawrence D and Pilkington GJ (1995) Synergism between growth factors in the control of glioma cell proliferation, migration and invasion in vitro, Int J Oncol 6: 1079-1085
16. Nakano A, Tani E, Miyazaki K, Furuyama J and Matsumoto T (1993) Expression of matrilysin and stromelysin in human glioma cells. Biochem Res Commun 192: 999-1003
17. Nicolson GL, Nakajima M, Herrmann JL, Menter DG, Cavanaugh PG, Park SJ and Marchelti D (1994) Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neuro-Oncol 18: 139-149
18. Overall CM, Wrana JL and Sodek J (1991) Transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor β-1 in human fibroblasts. J Biol Chem 226: 14064-14071
19. Pedersen P-H, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR and Laerum OD (1994) Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-α, bFGF, 1L-2] on glioma sphcriod growth, migration and invasion. Int J Cancer 56: 255-261
20. Pilkington GJ, Dunan JR, Rogers JP, Clarke TM and Knott JCA (1993) Growth factor modulation of surface ganglioside expression in cloned neoplastic glia. Neurosci Lett 149: 1-5
21. Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osmon F, Stetler-Stevenson WG, Liotta LA and Sawaya R (1994) Role of plasminogen activator and 92-kDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neuro-Oncol 18: 129-138
22. Reubi JC, Horisberger U, Lang W, Koper JW, Braakman R and Lamberts SW (1989) Coincidence of EGF receptors and somatostatin receptors in mcningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 134: 337-344
23. Romanic AM and Madri JA (1994) Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 4: 145-156
24. Rooprai HK and McCormick D (1997) Proteases and their inhibitors in human brain tumours: a review. Anticancer Res 17: 4152-4162
25. Rooprai HK, Van Meter T, Rucklidge GJ, Hudson L, Everall IP and Pilkington GJ (1998) Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int J Oncol 13: 1153-1157
26. Rossi M, Rooprai HK, Maidment SL, Rucklidge GJ and Pilkington GJ (1996) The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells. Anticancer Res 16: 121-128
27. Rucklidge GJ, Lund-Johansen M, Milne G and Bjerkvig R (1990) Isolation and characterization of a metalloproteinase secreted by rat glioma cells in serum-free culture. Biochem Biophys Res Commun 172: 544-550
28. Russell DS and Rubenstein LJ (1989) Pathology of Tumours of the Nervous System, 5th edn. pp. 83-289, Williams & Wilkins: Baltimore
29. Salo T, Lyons JG, Rahematulla F, Birkendal-Hansen H and Larjava H (1991) Transforming growth factor β-1 upregulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 226: 11436-11441
30. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT and Liotta LA (1990) Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumour cell lines and human tumour tissues. J Biol Chem 265: 13933-13938
31. Tamaki M, McDonald W and Del Maestro RF (1998) The importance of cell density in the interpretation of growth factor effects on collagenase IV activity release and extracellular matrix production from C6 astrocytoma cells. J Neuro-Oncol 39; 205-216
32. Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB 5: 2145-2154
33. Yamada KM (1983) Cell surface interactions with extracellular material. Ann Rev Biochem 52: 761-799